DADC
MDCO

D.A. Davidson & Co’s Medicines Co MDCO Stock Holding History

D.A. Davidson & Co’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,750
Closed -$104K – 2219
2017
Q2 		$104K Hold
2,750
– – ﹤0.01% 1247
2017
Q1 		$134K Hold
2,750
– – ﹤0.01% 1118
2016
Q4 		$93K Hold
2,750
– – ﹤0.01% 1335
2016
Q3 		$103K Sell
2,750
-450
-14% -$17K ﹤0.01% 1223
2016
Q2 		$107K Buy
3,200
+2,750
+611% +$97K ﹤0.01% 1090
2016
Q1 		$14K Hold
450
– – ﹤0.01% 1830
2015
Q4 		$16K Buy
+450
New +$17K ﹤0.01% 1775
2014
Q1 		– Sell
-109
Closed -$4K – 2240
2013
Q4 		$4K Buy
+109
New +$3.9K ﹤0.01% 1905

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.A. Davidson & Co's MDCO Position: Q3 2017 in Review

D.A. Davidson & Co sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 2,750 shares — an estimated $104K sold.

D.A. Davidson & Co first reported a position in MDCO in Q4 2013 and held it in 8 quarters. The position peaked at $134K in Q1 2017. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

  • D.A. Davidson & Co reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 2,750 Medicines Co shares in Q3 2017, an estimated $104K.
  • D.A. Davidson & Co first reported a position in Medicines Co in Q4 2013 and held it in 8 quarters.
  • D.A. Davidson & Co's Medicines Co position peaked at $134K in Q1 2017.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.